rhenium has been researched along with Carcinoma, Transitional Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, Y; Muranaka, A; Nagai, K; Otsuka, N; Terashima, H; Yanagimoto, S; Yoneda, M | 1 |
| Bishop, MC; Denton, G; Murray, A; Perkins, AC; Price, MR; Scholfield, DP; Simms, MS; Vincent, RM | 1 |
2 other study(ies) available for rhenium and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Lymphoscintigraphy by sc injection of 67Ga-citrate.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Gallium Radioisotopes; HeLa Cells; Humans; Injections, Subcutaneous; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Macrophages; Male; Middle Aged; Mouth Neoplasms; Radionuclide Imaging; Rhenium; Technetium; Technetium Compounds; Urinary Bladder Neoplasms | 1982 |
Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancer.
Topics: Antibodies, Monoclonal; Antibody Specificity; Carcinoma, Transitional Cell; Chromatography, Gel; Drug Stability; Humans; In Vitro Techniques; Isotope Labeling; Mucin-1; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Rhenium; Urinary Bladder; Urinary Bladder Neoplasms | 2001 |